Covid research helped Swiss response, says Science Foundation
The National Science Foundation says it has funded important Covid-19 research in Switzerland which also helped the government to adapt its recommendations.
Keystone / Michael Buholzer
The National Science Foundation's CHF45 million ($45.8 million) support to Covid-19 research in Switzerland has made an important contribution to tackling the pandemic so far, it saidExternal link on Tuesday.
This content was published on
2 minutes
RTS/jc
Despite high pressure and sometimes difficult working conditions, researchers have presented impressive results, said epidemiologist Marcel Salathé of the Federal Technology Institute Lausanne (EPFL) who chairs the steering committee of the National Research Programme “Covid-19”. This programme includes 200 researchers involved in 28 projects with a total of CHF20 million.
In the early phase of the pandemic, epidemiological and monitoring projects provided important findings on the transmissibility of the virus, mobility patterns of the population during the partial lockdown, and degree of acceptance of restrictions, which allowed the Swiss government to adapt its recommendations, says the Science Foundation.
Another early milestone was the development of an inexpensive mass test by EPFL researchers which made it possible for the first time to detect Covid-19-specific antibodies in broad population groups, including in kindergartens.
It says EAWAGExternal link wastewater monitoring, which measures the concentration of Covid-19 viruses in water bodies, was a “resounding success” and has now been extended to over a hundred sites.
Important findings in the biomedical field include effects of the virus on children, on the mental and cognitive health of adults, and recognition of Long Covid as a health problem that is still not sufficiently understood, according to the press release.
Results from tests on Covid-19 patients of drugs originally developed for other diseases were more mixed. Although there were some “successful approaches”, some studies were also discontinued “as the strategies pursued proved ineffective”, says the science foundation.
Ongoing research includes the development of new vaccines and a nasal spray vaccine for Covid-19.
Popular Stories
More
Swiss Politics
Why cars still reign supreme in ‘rail-nation’ Switzerland
Uri voters clear path for hotel and marina complex in central Switzerland
This content was published on
Voters in canton Uri in central Switzerland have rejected a Green Party initiative aimed at regulating the development of the lakeside site in Isleten.
Valais voters reject plan to achieve carbon neutrality by 2040
This content was published on
Voters in canton Valais in southern Switzerland have turned down a proposal for the region to achieve carbon neutrality by 2040.
Swiss central banker wants to boost equity to head off risks
This content was published on
Equity levels at the Swiss National Bank (SNB) are much too low for the risks its large balance sheet poses, according to Martin Schlegel.
Swiss and German virologists raise hopes of nasal coronavirus vaccine
This content was published on
Swiss and German virologists working on a nasal vaccine for Covid-19 say such a technique could be much more effective against the virus.
Swiss researchers discover antibody signature that could predict Long Covid
This content was published on
Immunologists in Zurich found lower levels of two types of immunoglobulins in patients who developed post-acute Covid-19 syndrome.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.